tanshinone ii a has been researched along with benzofurans in 11 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (benzofurans) | Trials (benzofurans) | Recent Studies (post-2010) (benzofurans) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 13,293 | 451 | 4,970 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Li, S; Liu, H; Liu, J; Zhang, W | 1 |
| Li, YS; Liang, QS; Wang, J; Wang, ZH; Yan, L; Yang, GT; Yong, YQ; Zheng, Z | 1 |
| Li, F; Song, L; Tang, L; Tian, F; Wang, Z; Yang, J; Yu, Z | 1 |
| Barthwal, MK; Bogra, J; Dikshit, M; Kohli, M; Kothari, N; Rana, M; Singh, A; Singh, V; Tiwari, RL; Verma, A | 1 |
| Guan, YT; Han, Y; Jiang, JM; Qin, Y; Wang, JN; Wu, XH; Xie, HJ; Yu, ZL | 1 |
| Fu, TM; Guo, LW; Lu, J; Pan, LM; Zhang, M; Zhu, HX | 1 |
| Chan, P; Chen, JJ; Cheng, TH; Hong, HJ; Liu, JC; Shih, NL; Zhuang, S | 1 |
| Han, G; Li, F; Wu, K | 1 |
| Gong, YP; Guo, Y; Huang, XO; Li, Y; Ma, HB; Wang, FF; Xiang, B | 1 |
| Guo, Z; Kong, D; Wang, Q; Yang, W; Yu, Y; Zhang, L | 1 |
| Fan, C; Li, K; Li, S; Wu, C; Yu, G; Zhang, P | 1 |
11 other study(ies) available for tanshinone ii a and benzofurans
| Article | Year |
|---|---|
Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: Influence of Poloxamer 188 coating on phagocytic uptake.
Topics: Animals; Benzofurans; Drug Delivery Systems; Drug Design; Humans; Lipids; Macrophages; Mice; Nanoparticles; Particle Size; Phagocytosis; Plant Extracts; Poloxamer; Polyethylene Glycols; Rhodamines; Scattering, Radiation | 2008 |
[Effect of tashinone on nitric oxide synthase in hypertrophic cardiomyocyte of rats suffered abdominal aorta constriction].
Topics: Animals; Aorta, Abdominal; Benzofurans; Blood Pressure; Cardiomyopathy, Hypertrophic; Constriction, Pathologic; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Endothelium, Vascular; Female; Gene Expression Regulation, Enzymologic; Heart Ventricles; Male; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Protein Kinase C; Rats; RNA, Messenger | 2008 |
Clinical research of Tashinone IIA combined with endocrine therapy in treating advanced-stage prostate cancer.
Topics: Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Hemoglobins; Humans; Leuprolide; Male; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Tosyl Compounds; Treatment Outcome | 2014 |
PKCδ-IRAK1 axis regulates oxidized LDL-induced IL-1β production in monocytes.
Topics: Acetophenones; Acetylcysteine; Adult; Benzofurans; Benzopyrans; Carbazoles; Female; Humans; Indoles; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Lipoproteins, LDL; Male; Middle Aged; Monocytes; Onium Compounds; Protein Kinase C-delta; Reactive Oxygen Species; Systemic Inflammatory Response Syndrome; THP-1 Cells; Toll-Like Receptors | 2014 |
Tanshinone IIA Prevents Rat Basilar Artery Smooth Muscle Cells Proliferation by Inactivation of PDK1 During the Development of Hypertension.
Topics: Animals; Basilar Artery; Benzofurans; Blood Pressure; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Endothelin-1; Hypertension; Hypertension, Renovascular; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Rats, Sprague-Dawley | 2015 |
[Studies on preparation by SPG membrane emulsification method and in vitro characterization of tetradrine-tashionone II(A)-PLGA composite microspheres].
Topics: Benzofurans; Benzylisoquinolines; Drug Carriers; Drug Compounding; Drugs, Chinese Herbal; Kinetics; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Tanshinone IIA Induces Heme Oxygenase 1 Expression and Inhibits Cyclic Strain-Induced Interleukin 8 Expression in Vascular Endothelial Cells.
Topics: Benzofurans; Enzyme Induction; Gene Expression; Gene Silencing; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-8; NF-E2-Related Factor 2; Phosphatidylinositol 3-Kinases; Salvia miltiorrhiza | 2016 |
Tanshinone IIA Alleviates the AD Phenotypes in APP and PS1 Transgenic Mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Benzofurans; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Presenilin-1 | 2016 |
The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway.
Topics: Acute Disease; Adolescent; Adult; Aged, 80 and over; Benzofurans; Cytotoxins; Drug Synergism; Female; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Imidazoles; Leukemia; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53 | 2019 |
Tanshinone II A Affects Diabetic Peripheral Neuropathic Pain via Spinal Dorsal Horn Neuronal Circuitry by Modulating Endoplasmic Reticulum Stress Pathways.
Topics: Animals; Benzofurans; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Endoplasmic Reticulum Stress; Male; Rats; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Synaptic Transmission | 2020 |
Tanshinone II A improves the chemosensitivity of breast cancer cells to doxorubicin by inhibiting β-catenin nuclear translocation.
Topics: Active Transport, Cell Nucleus; Benzofurans; beta Catenin; Breast Neoplasms; Cell Nucleus; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Neoplasm Proteins | 2021 |